Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

NOVOZYMES NORTH AMERICA, INC.

Filed by NOVOZYMES NORTH AMERICA, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 20, 2026
Income
Not reported
Expenses
$220,000.00
Filing UUID
cb049006-b9d2-4ab5-9c22-f6acc99e17a6
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

ENV · Environment/Superfund

Issues related to renewables fuels and E-15 - no specific legislation.

AGR · Agriculture

Issues related to sustainability - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. H.R. 7366 - Dietary Supplement Regulatory Uniformity Act - Issues related to dietary supplements.

Literal federal measure citations: H.R.2756, S.1387, H.R. 7366

TRA · Transportation

Issues pertaining to Supply Chain including movement of containers - no specific legislation. SHIP It Act (not yet introduced) - issues related to tariffs.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.